Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-05-09FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic Metoprolol Succinate product from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS withdrawal · 2023-05-06Clinical Trial Update: Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD [Phase 4]
A Phase 4 trial comparing sacubitril-valsartan to usual antihypertensives in patients with congestive heart failure and hypertension has bee…
-
FDA approval · 2023-05-05FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a supplemental application for metoprolol succinate from Zydus Pharmaceuticals (USA) Inc., approving its generic product under …
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension [Phase 2]
Phase 2 trial evaluating safety and effects of SLx-2101 taken up to 14 days on blood pressure in patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension [Phase 4]
Phase 4 clinical trial evaluating the effect of azilsartan on atrial fibrillation in patients with hypertension is ongoing or status unknown…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-01FDA Approved: TELMISARTAN — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for Telmisartan submitted by Chartwell RX, LLC.
-
FDA approval · 2023-05-01FDA Approved: NIFEDIPINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for nifedipine from Ingenus Pharmaceuticals, LLC, for an already approved generic nifedipine product…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Tailored to You (TTY) Pilot Study [NA]
Pilot study update for the Tailored to You program in hypertension; study completed with results posted.
-
FDA label_change · 2023-04-26FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for the telmisartan and hydrochlorothiazide combination product, updating its labeling.
-
FDA approval · 2023-04-25FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for a metoprolol tartrate and hydrochlorothiazide combination product from Sun Pharmaceutical Indust…
-
FDA approval · 2023-04-25FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Telmisartan submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2023-04-20FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Mylan Pharmaceuticals Inc., potentially updating label…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: HIRREM for Stage 1 Primary Hypertension [NA]
A completed clinical trial investigating HIRREM for stage 1 primary hypertension; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia [Phase 4]
Phase 4 clinical trial evaluating the effect of mineralocorticoid receptor antagonist (MRA) on cardiovascular disease in patients with hyper…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism [Phase 4]
Phase 4 trial comparing finerenone and spironolactone for primary aldosteronism and hypertension.
-
FDA approval · 2023-04-14FDA Approved: KAPSPARGO — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for KAPSPARGO (metoprolol succinate) by Sun Pharmaceutical Industries.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Vascular Dysfunction in Human Obesity Hypertension [Phase 2]
Phase 2 trial on vascular dysfunction in human obesity hypertension was terminated; results posted earlier, updating on obesity-related vasc…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability. [Phase 4]
Phase 4 clinical trial update evaluating the effect of a nitrendipine/atenolol combination on blood pressure variability in individuals with…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. [Phase 4]
A Phase 4 trial comparing sacubitril/valsartan with amlodipine in patients with hypertension and left ventricular hypertrophy.
-
FDA approval · 2023-04-11FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application from Mylan Pharmaceuticals for a generic amlodipine/valsartan combination product.
-
EMA approval · 2023-04-11EMA Authorised: Granpidam (sildenafil citrate) — Accord Healthcare S.L.U.
Granpidam (sildenafil citrate) has been authorised in the EU for use in hypertension and pulmonary hypertension with Accord Healthcare S.L.U…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension [Phase 2]
Phase 2 trial evaluating ETC-1002 in people with high cholesterol and high blood pressure has completed; results posted.
-
FDA approval · 2023-03-30FDA Approved: NEBIVOLOL — Original Application (Apnar Pharma LP)
The FDA approved nebivolol hydrochloride as a generic drug under an original ANDA filed by Apnar Pharma LP.
-
FDA approval · 2023-03-22FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a combination product containing amlodipine and valsartan.
-
FDA approval · 2023-03-21FDA Approved: TELMISARTAN — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Telmisartan submitted by Zydus Lifesciences Limited.